All In MedTech

FDA Clearance Tracker · P150004-S043

Proclaim DRG IPG

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 5, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 5, 2021

Approved

Time to decision

177 days

Received Sep 9, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150004-S043
Device name
Proclaim DRG IPG
Applicant location
Plano, TX
Received
Sep 9, 2020
Decided
Mar 5, 2021
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150004

Device type

Device class
Class III

Every decision under product code PMP

FDA's approval statement

As written in FDA's record.

Approval for an update to the Clinician Programmer Application and Patient Controller Application to version 202.0 to include a Remote Care feature that facilitates remote communication between the Clinician Programmer Application and Patient Programmer Application.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.